PM Matovič defends his wife, accused of preferential treatment

He calls the reports an attempt to discredit him. Opposition parties ask for documents proving his claims.

PM Igor Matovič at September 19 press conference.PM Igor Matovič at September 19 press conference. (Source: TASR)

Although Igor Matovič has been describing himself as a fighter against corruption and the anti-corruption agenda helped his movement win the February general election, he remained silent about accusations concerning his wife for several days.

The Plus 7 Dní weekly was the first to report on September 16 that Matovič’s wife Pavlína allegedly invested in one of the companies belonging to the portfolio of Arca Capital, recently mired in financial problems, and given preferential treatment, unlike other creditors.

Later, the opposition parties Smer and Hlas joined the criticism.

Matovič himself responded only after a few days, calling the matter an attempt to discredit him.

The rest of this article is premium content at Spectator.sk
Subscribe now for full access

I already have subscription - Sign in

Subscription provides you with:
  • Immediate access to all locked articles (premium content) on Spectator.sk
  • Special weekly news summary + an audio recording with a weekly news summary to listen to at your convenience (received on a weekly basis directly to your e-mail)
  • PDF version of the latest issue of our newspaper, The Slovak Spectator, emailed directly to you
  • Access to all premium content on Sme.sk and Korzar.sk

Get daily Slovak news directly to your inbox

Theme: Corruption & scandals

Read more articles by the topic

Top stories

News digest: What Jankovská said and Kollár goes home amid scandal

Nationwide testing put on hold. Speaker of parliament received visitors in hospital despite a ban. Foreigners' Police change office hours around Christmas.

Speaker of Parliament Boris Kollár

Developed at home, the production of Slovakia's COVID-19 vaccine will move abroad

Neuroimmunologist Norbert Žilka oversees the development of the ACvac1 vaccine at Axon Neuroscience.

Norbert Žilka is the director of the Institute of Neuroimmunology of the Slovak Academy of Sciences (SAV) and also the scientific director of Axon Neuroscience.